Cargando…
Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report
Sodium and fluid retention is a hallmark and a therapeutic challenge of the nephrotic syndrome (NS). Studies support the “overfill” theory of NS with pathophysiological proteolytic activation of the epithelial sodium channel (ENaC) which explains the common observation of suppressed renin –angiotens...
Autores principales: | Hinrichs, Gitte R., Mortensen, Line A., Jensen, Boye L., Bistrup, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016639/ https://www.ncbi.nlm.nih.gov/pubmed/29939487 http://dx.doi.org/10.14814/phy2.13743 |
Ejemplares similares
-
Treatment of Nephrogenic Diabetes Insipidus Patients With cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability
por: Hinrichs, Gitte R., et al.
Publicado: (2020) -
Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023) -
Amiloride-Sensitive Sodium Channels and Pulmonary Edema
por: Althaus, Mike, et al.
Publicado: (2011) -
A Novel AQP2 Sequence Variant Causing Aquaporin-2 Retention in the Cytoplasm and Autosomal Dominant Nephrogenic Diabetes Insipidus
por: Hinrichs, Gitte R., et al.
Publicado: (2022) -
Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome
por: Gipson, Debbie S., et al.
Publicado: (2023)